FDA Approves First Drug for Cold Agglutinin Disease
Sutimlimab-jome is the first drug to have FDA approval for the treatment cold agglutinin disease, a rare autoimmune hemolytic anemia in which antibodies destroy red blood cells. FDA Approvals